Zimbuck – Your Market. Your Community.
BREAKING: Claritev jumps 19% as revenue tops estimates

Claritev (NYSE: CTEV) surged 19.5% to $28.67 on Tuesday after its Q3 results beat expectations. Revenue rose 9.1% year over year to $268.3 million — the highest quarterly revenue in 17 quarters — topping estimates, while the quarterly loss narrowed to $3.64 a share. Management also raised full-year revenue guidance to about $1.04 billion.

#Claritev #CTEV #Stocks #Earnings #StockMarket #Healthcare
Like
Love
6
86 Views